Nobody except delusional longs and shills on this board think this is "at the point of getting an approval decision". Even at the snowballs chance in hell of approval, there would be no reimbursement, just like there isn't for Optune. Companies at the point of getting an approval generally go up, not hit 52 week lows. They usually aren't toiling away on the OTC either. And those companies are at the point of getting approval from the FDA, not the MHRA, and there is no submission for solid cancers or combos with DCVax or anything else on your Fantasy Island.
Market Data 
Markets 
AI
